Letter to the Editor
Efficacy and safety of semaglutide in a diabetic and obese patient on incremental hemodialysis. Does it also contribute to preserving residual renal function?
Eficacia y seguridad de la semaglutide en un paciente diabético y obeso en hemodiálisis incremental. ¿Contribuye también a preservar la función renal residual?
José Carlos de la Flora,
, Javier Deirab, Tania Monzónc, Francisco Valgad, Cristina Albarracína, Elisa Ruiza, Miguel Rodelesa
Corresponding author
a Servicio de Nefrología, Hospital central de la defensa Gómez Ulla, Madrid, Spain
b Servicio de Nefrología, Hospital San Pedro de Alcántara, Cáceres, Spain
c Unidad de Hemodiálisis, Avericum S.L., Las Palmas de Gran Canarias, Spain
d Servicio de Nefrología, Hospital Universitario Dr. Negrín, Las Palmas de Gran Canarias, Spain
Read
2870
Timeswas read the article
1002
Total PDF
1868
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2024 December | 70 | 37 | 107 |
| 2024 November | 116 | 72 | 188 |
| 2024 October | 128 | 54 | 182 |
| 2024 September | 163 | 64 | 227 |
| 2024 August | 159 | 104 | 263 |
| 2024 July | 141 | 48 | 189 |
| 2024 June | 163 | 62 | 225 |
| 2024 May | 136 | 66 | 202 |
| 2024 April | 101 | 46 | 147 |
| 2024 March | 87 | 44 | 131 |
| 2024 February | 114 | 54 | 168 |
| 2024 January | 81 | 41 | 122 |
| 2023 December | 63 | 44 | 107 |
| 2023 November | 193 | 68 | 261 |
| 2023 October | 80 | 84 | 164 |
| 2023 September | 72 | 114 | 186 |
| 2023 August | 1 | 0 | 1 |
Show all
